Molecular basis of mantle cell lymphoma
- PMID: 14687022
- DOI: 10.1046/j.1365-2141.2003.04761.x
Molecular basis of mantle cell lymphoma
Similar articles
-
Atypical cytogenetic presentation of t(11;14) in mantle cell lymphoma.Haematologica. 2005 Dec;90(12):1708-9. Haematologica. 2005. PMID: 16330452
-
Multiple recurrent chromosomal breakpoints in mantle cell lymphoma revealed by a combination of molecular cytogenetic techniques.Genes Chromosomes Cancer. 2008 Dec;47(12):1086-97. doi: 10.1002/gcc.20609. Genes Chromosomes Cancer. 2008. PMID: 18709664
-
One translocation for 2 lymphoid neoplasms.Blood. 2019 Jan 10;133(2):180. doi: 10.1182/blood-2018-10-877357. Blood. 2019. PMID: 30630847 No abstract available.
-
Mantle cell lymphoma.Curr Opin Hematol. 2004 Nov;11(6):411-8. doi: 10.1097/01.moh.0000138682.13354.da. Curr Opin Hematol. 2004. PMID: 15548996 Review.
-
Mantle cell lymphoma lacking the t(11;14) translocation: a case report and brief review of the literature.J Clin Pathol. 2008 Jul;61(7):869-70. doi: 10.1136/jcp.2007.048629. J Clin Pathol. 2008. PMID: 18587018 Review.
Cited by
-
Temsirolimus in the treatment of relapsed or refractory mantle cell lymphoma.Onco Targets Ther. 2010 Sep 7;3:167-78. doi: 10.2147/ott.s8147. Onco Targets Ther. 2010. PMID: 20856791 Free PMC article.
-
Synchronous adenocarcinoma and mantle cell lymphoma of the stomach.Yonsei Med J. 2007 Dec 31;48(6):1061-5. doi: 10.3349/ymj.2007.48.6.1061. Yonsei Med J. 2007. PMID: 18159604 Free PMC article.
-
Long-term results of the treatment of patients with mantle cell lymphoma with cladribine (2-CDA) alone (95-80-53) or 2-CDA and rituximab (N0189) in the North Central Cancer Treatment Group.Cancer. 2008 Jul 1;113(1):108-16. doi: 10.1002/cncr.23537. Cancer. 2008. PMID: 18470909 Free PMC article. Clinical Trial.
-
Phospholipid scramblase 1 as a critical node at the crossroad between autophagy and apoptosis in mantle cell lymphoma.Oncotarget. 2016 Jul 5;7(27):41913-41928. doi: 10.18632/oncotarget.9630. Oncotarget. 2016. PMID: 27248824 Free PMC article.
-
Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma.Int J Hematol. 2010 Nov;92(4):563-70. doi: 10.1007/s12185-010-0707-5. Epub 2010 Oct 23. Int J Hematol. 2010. PMID: 20972652 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources